Yamei Liu
Binlan Fu
Xiaoman Li1,2
Chen Chen
Xican Li
Liangliang Xu
Bin Wang
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, China
- 2Laboratory of Orthopedics and Traumatology, Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China
- 3School of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
- 4The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
- 5Department of Traumatology, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
by Liu Y, Fu B, Li X, Chen C, Li X, Xu L and Wang B (2022). Front. Pharmacol. 13:1007839. doi: 10.3389/fphar.2022.1007839
In the published article, there was an error in Figure 5 as published. In Figure 5E, the position of the experimental images of DEX group and DEX + BHD group is inverted, that is, the images of DEX group should appear in DEX + BHD group, while the images of DEX + BHD group should appear in DEX group. The corrected Figure 5 and its caption appear below.
FIGURE 5
FIGURE 5. BHD affects osteoclast formation and differentiation by suppressing the expression of the NF-κB signaling pathway in vivo. (A–E) Representative images of Immunohistochemical staining of decalcified bone sections. Scale bar = 20 μm.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: bushen huoxue decoction, osteoporosis, NF-κB pathway, ERK pathway, JNK pathway
Citation: Liu Y, Fu B, Li X, Chen C, Li X, Xu L and Wang B (2023) Corrigendum: Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways. Front. Pharmacol. 14:1148908. doi: 10.3389/fphar.2023.1148908
Received: 20 January 2023; Accepted: 17 February 2023;
Published: 27 February 2023.
Edited and reviewed by:
Chang-Hee Suh, Ajou University, Republic of KoreaCopyright © 2023 Liu, Fu, Li, Chen, Li, Xu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bin Wang, Z3p0Y213YW5nYmluMTk3M0AxNjMuY29t; Liangliang Xu, eHVsbC0yMDE2QGd6dWNtLmVkdS5jbg==
†These authors have contributed equally to this work and share first authorship